AEON Biopharma Appoints John Bencich as Chief Financial Officer

AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX ® (onabotulinumtoxinA) to achieve ...

AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting

AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX ® (onabotulinumtoxinA) to achieve ...
TMCnet

AEON Releases 2025 Payment Data, Highlighting Growth of AI-Native Payments

HONG KONG, Feb. 26, 2026 /PRNewswire/ -- AEON, the foundational payment and settlement layer for the new AI economy, today released its 2025 payment performance data, highlighting the accelerating ...
Gulf Today

Redefining men’s health: AEON Clinic introduces advanced urologic & performance solutions

The American Board of Regenerative Medicine has endorsed AEON Clinic, the first regenerative wellness facility in the Middle East, today unveiled its whole ...

Aeon Biopharma Appoints John Bencich as Finance Chief

Aeon has been contracting interim finance chiefs in recent years and Jennifer Sy was serving as chief accounting officer. Aeon said Monday it signed an employment agreement with Sy setting forth the ...